Copyright
©2014 Baishideng Publishing Group Co.
World J Diabetes. Apr 15, 2014; 5(2): 209-218
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.209
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.209
Table 4 IC50 inhibitory values of Eucalyptus extracts E. globulus, E. citriodora and E. camaldulensis in different assays
Assays | EG | EC | ECA |
α-amylase | 3.01 ± 0.01 | 4.13 ± 0.09 | 3.65 ± 1.04 |
α-glucosidase | 2.08 ± 0.01 | 2.68 ± 0.11 | 2.11 ± 0.19 |
Aldose reductase | 2.06 ± 0.03 | 6.72 ± 0.65 | 2.56 ± 0.84 |
Angiotensin converting enzyme | 4.31 ± 0.09 | 30.83 ± 0.45 | 6.85 ± 0.98 |
Dipeptidyl peptidase | 3.098 ± 0.09 | 6.138 ± 0.68 | 3.99 ± 0.91 |
1,1-diphenyl-2- picrylhydrazyl (DPPH) | 12.32 ± 0.91 | 68.42 ± 0.05 | 14.44 ± 1.91 |
-
Citation: Dey B, Mitra A, Katakam P, Singla RK. Exploration of natural enzyme inhibitors with hypoglycemic potentials amongst
Eucalyptus Spp. byin vitro assays. World J Diabetes 2014; 5(2): 209-218 - URL: https://www.wjgnet.com/1948-9358/full/v5/i2/209.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i2.209